| Line Item | 2022-04-02 | Y/Y |
|---|---|---|
| Revenue | $4.65B | +15.7% |
| Cost of Revenue | $2.36B | +10.7% |
| Gross Profit | $2.29B | +21.4% |
| R&D Expense | $623.6M | +9.3% |
| SG&A Expense | $349.7M | -4.8% |
| Operating Income | $1.23B | +35.2% |
| Interest Expense | $63.3M | -15.8% |
| Pre-tax Income | $1.18B | +46.3% |
| Income Tax | $147.7M |
| Line Item | 2022-04-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $972.6M | -30.4% |
| Accounts Receivable | $568.9M | +24.4% |
| Inventory | $755.7M | +48.8% |
| Current Assets | $2.45B | -1.4% |
| Total Assets | $7.51B | +4.0% |
| Current Liabilities | $675.1M | -0.9% |
| Long-term Debt | $2.05B | +17.5% |
| Line Item | 2022-04-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.05B | -19.4% |
| Capital Expenditures | $213.5M | +14.2% |
| Investing Cash Flow | -$596.0M | -172.6% |
| Financing Cash Flow | -$875.5M | -117.8% |
| Free Cash Flow | $835.8M | -25.0% |
| +100.3% |
| Net Income | $1.03B | +40.9% |
| EPS (Basic) | $9.38 | +45.9% |
| EPS (Diluted) | $9.26 | +46.5% |
| Total Liabilities |
| $2.96B |
| +14.0% |
| Stockholders' Equity | $4.55B | -1.6% |